No increased risk of thrombosis in heterozygous congenital dysplasminogenemia

International Journal of Hematology

Volumn 72, Issue 2, 2000, Pages 247-252

  Shigekiyo, Toshio ^a  

^a TOKUSHIMA PREFECTURAL CENTRAL HOSPITAL   (Japan)

Author keywords

Congenital dysplasminogenemia; Plasminogen; Plasminogen tochigi; Thrombosis

Indexed keywords

PLASMINOGEN;

ADOLESCENT; ADULT; AGED; AMINO ACID SUBSTITUTION; ARTICLE; FAMILY HEALTH; FEMALE; GENETICS; HETEROZYGOTE; HUMAN; MALE; MIDDLE AGED; MUTATION; PEDIGREE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; THROMBOSIS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMINO ACID SUBSTITUTION; FAMILY HEALTH; FEMALE; HETEROZYGOTE; HUMANS; MALE; MIDDLE AGED; MUTATION; PEDIGREE; PLASMINOGEN; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RISK FACTORS; THROMBOSIS;

EID: 0034243387     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (3)

1. Petersen TE, Martzen MR, Ichinose A, Davie ER. Characterization of the gene for human plasminogen, a key proenzyme in the fibrinolytic system. J Biol Chem. 1990;265:6104-6111.
2. Robbins KC, Summaria L, Hsieh B, Shah RJ. The peptide chains of human plasmin: mechanism of activation of human plasminogen to plasmin. J Biol Chem. 1967;242:2333-2342.
3. De Stefano V, Finazzi G, Mannucci M. Inherited thrombophilia: pathogenesis, clinical syndromes, and management. Blood. 1996;87:3531-3544.